Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CV Sciences (CVSI) Research & Development (2016 - 2025)

CV Sciences' Research & Development history spans 13 years, with the latest figure at -$4000.0 for Q4 2025.

  • On a quarterly basis, Research & Development fell 157.14% to -$4000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $100000.0, a 0.0% change, with the full-year FY2025 number at $100000.0, changed 0.0% from a year prior.
  • Research & Development hit -$4000.0 in Q4 2025 for CV Sciences, down from $24000.0 in the prior quarter.
  • Over the last five years, Research & Development for CVSI hit a ceiling of $410000.0 in Q3 2021 and a floor of -$4000.0 in Q4 2025.
  • Historically, Research & Development has averaged $94600.0 across 5 years, with a median of $40000.0 in 2022.
  • Biggest five-year swings in Research & Development: skyrocketed 122.5% in 2023 and later tumbled 157.14% in 2025.
  • Tracing CVSI's Research & Development over 5 years: stood at $364000.0 in 2021, then plummeted by 89.01% to $40000.0 in 2022, then skyrocketed by 122.5% to $89000.0 in 2023, then crashed by 92.13% to $7000.0 in 2024, then tumbled by 157.14% to -$4000.0 in 2025.
  • Business Quant data shows Research & Development for CVSI at -$4000.0 in Q4 2025, $24000.0 in Q3 2025, and $50000.0 in Q2 2025.